- Operative Positioning Technique for an Intertrochanteric Fracture in a Patient with an Ipsilateral Above-the-Knee Amputation - Technical Note -
-
Park DH, Kwon YU, Kim DS
- KMID: 2521504
- J Korean Fract Soc.
- 2021 Oct;34(4):137-141.
- doi: 10.12671/jkfs.2021.34.4.137
A 45-year-old man with a remote history of a left above-the-knee amputation presented to the emergency department with left hip pain after a mechanical fall. This case was an operative... -
- CITED
-
- Close
- SHARE
-
- Close
- Denosumab (RANKL Inhibitor): A Potent Anti-Resorptive Agent
-
Byun SE
- KMID: 2521505
- J Korean Fract Soc.
- 2021 Oct;34(4):142-147.
- doi: 10.12671/jkfs.2021.34.4.142
Denosumab, a fully human monoclonal antibody to the receptor activator of nuclear factor-kappa B ligand, was introduced and used as an anti-osteoporotic agent. Denosumab prevents bone resorption by inhibiting the... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparing Outcomes of Retrograde Intramedullary Nail and Locking Plate Fixation in Distal Femoral Fractures
-
Yoon BH, Hwang BK, Oh HK, Choo SK, Sohn JM, Sung YB
- KMID: 2521503
- J Korean Fract Soc.
- 2021 Oct;34(4):131-136.
- doi: 10.12671/jkfs.2021.34.4.131
Purpose: We compared the radiological and clinical results of fixation for distal femoral fracture (DFF) using a locking compression plate (LCP) or a retrograde intramedullary nail (RIN). Materials and Methods: From... -
- CITED
-
- Close
- SHARE
-
- Close
- Romosozumab: A Novel Agent in the Management of Osteoporosis
-
Moon NH, Shin WC, Jang JH
- KMID: 2521506
- J Korean Fract Soc.
- 2021 Oct;34(4):148-153.
- doi: 10.12671/jkfs.2021.34.4.148
With the discovery of screlostin as a pivotal player in bone metabolism, a novel medication targeting sclerostin has been introduced. Romosozumab, a humanized anti-sclerostin monoclonal antibody, is a unique approach... -
- CITED
-
- Close
- SHARE
-
- Close
